DARA BioSciences, Inc. is a development stage pharmaceutical company. The Company acquires therapeutic molecules and medical technologies directly or through investment in established companies. DARA focuses on small molecules from late preclinical development through phase 2 clinical trials for neuropathic pain, metabolic diseases, and dermatological disorders.